BCSI is an international medical device company based in Seattle, Washington, with European operations based in The Netherlands. BCSI's initial product is a closed-loop pH monitoring system for platelets introduced in 2007 to the blood bank industry in Europe. BCSI’s products are unique in that they do not violate the sterility of the platelet storage bag, a critical limitation of current products, and can be used anywhere along the blood collection/ distribution chain.
Company News
BCSI and CaridianBCT Sign Option Agreement Read More
BCSI Introduces Nucleic Acid Extraction Flat-Glass Technology Read More
Introducing:
BCSI's second product-
a flat-glass card for nucleic acid isolation. It is capable of quickly, easily, and reliably isolating nucleic acids (DNA and RNA) from blood and a variety of other biological samples.